Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.88 USD | +5.03% | +19.46% | +1.22% |
11:38am | Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating | MT |
May. 28 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
Evolution of the average Target Price on Corcept Therapeutics Incorporated
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Corcept Therapeutics Incorporated
Truist Securities | |
HC Wainwright | |
Canaccord Genuity | |
SVB Securities LLC | |
Piper Sandler | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- CORT Stock
- Consensus Corcept Therapeutics Incorporated